LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

Search

Pfizer

Uždarymo kaina

SektoriusSveikatos priežiūra

25.05 -0.08

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

24.95

Max

25.56

Pagrindiniai rodikliai

By Trading Economics

Pajamos

623M

3.6B

Pardavimai

2B

17B

P/E

Sektoriaus vid.

14.18

105.69

Pelnas, tenkantis vienai akcijai

0.87

Dividendų pajamingumas

6.96

Pelno marža

21.322

Darbuotojai

81,000

EBITDA

325M

5.6B

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+15.95% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

6.96%

2.37%

Kitas dividendų mokėjimo data

2025-12-01

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.5B

139B

Ankstesnė atidarymo kaina

25.13

Ankstesnė uždarymo kaina

25.05

Naujienos nuotaikos

By Acuity

39%

61%

148 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Pfizer Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-13 17:39; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Completes Acquisition of Metsera

2025-11-10 13:08; UTC

Pagrindinės rinkos jėgos
Įsigijimai, susijungimai, perėmimai

Metsera Shares Fall Premarket as Novo Throws in Towel on Bidding War

2025-11-10 09:41; UTC

Įsigijimai, susijungimai, perėmimai

Novo Nordisk Shares Rise After Withdrawal of Metsera Takeover Battle

2025-11-17 18:20; UTC

Įsigijimai, susijungimai, perėmimai

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

2025-11-14 12:22; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Pharma Sector Becoming Bidding Battlefield -- Market Talk

2025-11-13 16:26; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Completes Acquisition Of Metsera >PFE

2025-11-10 16:35; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Pfizer CEO Confident Metsera Therapies Will Get Approval -- Market Talk

2025-11-10 16:26; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Pfizer CEO: Metsera Has Exciting Weight-Loss Portfolio -- Market Talk

2025-11-10 15:36; UTC

Įsigijimai, susijungimai, perėmimai

What's Next for Novo Nordisk? -- WSJ

2025-11-10 14:05; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Pfizer Will See Big Benefits from Metsera Acquisition -- Market Talk

2025-11-10 12:33; UTC

Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, Monday.com, CoreWeave, and More -- Barrons.com

2025-11-10 12:32; UTC

Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, Monday.com, CoreWeave, and More -- Barrons.com

2025-11-10 10:45; UTC

Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, CoreWeave, and More -- Barrons.com

2025-11-10 10:34; UTC

Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, CoreWeave, and More -- Barrons.com

2025-11-10 10:32; UTC

Karštos akcijos

Stocks to Watch Monday: Metsera, Novo Nordisk, Nvidia, Tyson Foods -- WSJ

2025-11-10 09:26; UTC

Įsigijimai, susijungimai, perėmimai

Novo Nordisk Shares Rise After Withdrawal From Metsera Takeover Battle

2025-11-08 13:10; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

2025-11-08 03:50; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

2025-11-08 03:41; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

2025-11-08 03:07; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

2025-11-07 13:26; UTC

Įsigijimai, susijungimai, perėmimai

Correction to This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed. Article -- WSJ

2025-11-07 10:30; UTC

Įsigijimai, susijungimai, perėmimai

This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed. -- WSJ

2025-11-06 20:02; UTC

Įsigijimai, susijungimai, perėmimai

Biotech M&A Deals Are Trickier Than They Look. Watch the Milestone Payments. -- Barrons.com

2025-11-06 16:16; UTC

Uždarbis

Moderna's Quarter Wasn't As Bad as It Could Have Been. The Stock is Up -- Barrons.com

2025-11-06 12:29; UTC

Uždarbis

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

2025-11-06 12:15; UTC

Uždarbis

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

2025-11-06 00:24; UTC

Įsigijimai, susijungimai, perėmimai

Metsera: Pfizer Has Reiterated It Will Continue to Litigate >MTSR

2025-11-06 00:24; UTC

Įsigijimai, susijungimai, perėmimai

Metsera: Board of Directors Will Continue to Stand Firm on Behalf of Shareholders, Patients >MTSR

2025-11-06 00:24; UTC

Įsigijimai, susijungimai, perėmimai

Metsera: Gratified by Court Decision to Deny Pfizer's Request for Temporary Restraining Order to Block Board From Acting in Shareholders' Best Interests >MTSR

2025-11-06 00:22; UTC

Įsigijimai, susijungimai, perėmimai

Metsera Issues Statement in Response to Pfizer Litigation Ruling

Akcijų palyginimas

Kainos pokytis

Pfizer Prognozė

Kainos tikslas

By TipRanks

15.95% į viršų

12 mėnesių prognozė

Vidutinis 29.08 USD  15.95%

Aukščiausias 34 USD

Žemiausias 24 USD

Remiantis 15 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Pfizer kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

15 ratings

4

Pirkti

10

Laikyti

1

Parduoti

Techninis įvertinimas

By Trading Central

22.855 / 23.85Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

148 / 374 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat